AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 16, 2006). doi:10.1152/ajpheart.00395.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/H2680    most recent
00395.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venkatakrishnan, C D
Right arrow Articles by Ilangovan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venkatakrishnan, C D
Right arrow Articles by Ilangovan, G.
Submitted on April 14, 2006
Accepted on June 8, 2006

Heat Shock Protects Cardiac Cells From Doxorubicin-Induced Toxicity By Activating p38MAPK and Phosphorylation of Small Heat Shock Protein 27

C D Venkatakrishnan1, Arun K Tewari2, Leni Moldovan3, Arturo J Cardounel4, Jay L Zweier4, Periannan Kuppusamy1, and Govindasamy Ilangovan1*

1 Internal Medicine, The Ohio State University, Columbus, Ohio, United States
2 Physiology, The Ohio State University, Columbus, Ohio, United States; Internal Medicine, The Ohio State University, Columbus, Ohio, United States
3 Columbus , Ohio, United States; Internal Medicine, The Ohio State University, Columbus, Ohio, United States
4 Columbus, Ohio, United States; Internal Medicine, The Ohio State University, Columbus, Ohio, United States

* To whom correspondence should be addressed. E-mail: govindasamy.Ilangovan{at}osumc.edu.

Doxorubicin (DOX) and its derivatives are used as chemotherapeutic drugs to treat cancer patients. However, prolonged use of these drugs has been found to cause dilative cardiomyopathy and congestive heart failure due to the production of DOX-mediated reactive oxygen species (ROS). Thus, various preventive modalities have been developed to avoid this untoward side effect. In this paper, using cardiac cells, we report that the DOX- mediated oxidant-induced toxicity could be minimized by hyperthermia-induced small heat shock protein Hsp27; that is, this protein acts as an endogenous antioxidant against DOX-derived oxidants such as H2O2. Heat shock-induced Hsp27 was found to act as an anti-apoptotic protein (reducing ROS and Bax/Bcl2 ratio) against the DOX, and its phosphorylated isoforms were found to stabilize the F-actin remodeling in DOX treated cardiac cells and hence attenuating the toxicity. Further, protein kinase assays and proteomic analyses suggested that higher expression of Hsp27 and its phosphorylation are responsible for the observed protection in the heat-shocked cells. 2D gel electrophoresis showed 6 isoforms (non-phosphorylated and phosphorylated) of Hsp27. MALDI-TOF analyses showed two isoforms of Hsp27 ({alpha} and {beta}) are phosphorylated by various protein kinases. The S-15 and S-85 phosphorylation of Hsp27 by MAPKAP-2 was found to be the key mechanism in reducing apoptosis and facilitating F-actin remodeling. In conclusion, the present study illustrates that hyperthermia offers protection from DOX-induced cell death through induction and phosphorylation of Hsp27, and its anti-apoptotic and actin remodeling activities.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Stathopoulou, I. Beis, and C. Gaitanaki
MAPK signaling pathways are needed for survival of H9c2 cardiac myoblasts under extracellular alkalosis
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1319 - H1329.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, L. Ke, A.-J. Dijkhuis, X. Qi, A. Shiroshita-Takeshita, S. Nattel, R. H. Henning, and H. H. Kampinga
Heat shock proteins as molecular targets for intervention in atrial fibrillation
Cardiovasc Res, June 1, 2008; 78(3): 422 - 428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Venkatakrishnan, K. Dunsmore, H. Wong, S. Roy, C. K. Sen, A. Wani, J. L. Zweier, and G. Ilangovan
HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1736 - H1744.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Kardys, N. Rifai, O. Meilhac, J.-B. Michel, J. L. Martin-Ventura, J. E. Buring, P. Libby, and P. M Ridker
Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study
Clin. Chem., January 1, 2008; 54(1): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Li, I. S. Ali, and R. W. Currie
Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H74 - H87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Turakhia, C. D. Venkatakrishnan, K. Dunsmore, H. Wong, P. Kuppusamy, J. L. Zweier, and G. Ilangovan
Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3111 - H3121.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. J. J. M. Brundel, A. Shiroshita-Takeshita, X. Qi, Y.-H. Yeh, D. Chartier, I. C. van Gelder, R. H. Henning, H. H. Kampinga, and S. Nattel
Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation
Circ. Res., December 8, 2006; 99(12): 1394 - 1402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.